Datasheet is currently unavailable. Try again or CONTACT US
Datasheet

IKB alpha C-terminal Peptide

100-4167CP
50 µg
Liquid (sterile filtered)
Human
$132.00 /Per Item
Shipping info:

$50.00 to US & $70.00 to Canada for most products. Final costs are calculated at checkout.

Product Details

IKBα C-terminal Peptide - 100-4167CP
NF-kappa-B inhibitor alpha peptide, I-kappa-B-alpha antibody, IkB-alpha, IkappaBalpha, IKBA, MAD3, NFKBI, control peptide, blocking peptide
Human
Peptide

Target Details

Greater than 95% specific peptide

Application Details

Control peptide should be used at 1.0 µg per 1.0 µl of antiserum in per assay.

Formulation

1.0 mg/mL by dry weight
0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
0.01% (w/v) Sodium Azide
None

Shipping & Handling

Dry Ice
Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
Expiration date is six (6) months from date of receipt.
Intended for use as a control peptide when used with anti-IKB alpha C-terminal specific to block specific interaction of anti-IKB alpha C-terminal specific [p/n 100-4167C] with the IKB alpha subunit. I-kappa-B-alpha inhibits the activity of dimeric NF-kappa-B/REL complexes by trapping REL dimers in the cytoplasm through masking of their nuclear localization signals. On cellular stimulation by immune and proinflammatory responses, IKBA becomes phosphorylated promoting ubiquitination and degradation, enabling the dimeric RELA to translocate to the nucleus and activate transcription.

Invalid lot number

If you need help finding your CoA, contact us

This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.

Related products to: IKB alpha C-terminal Peptide